Education Library

Francesco Burzotta, MD, discusses the use of percutaneous mechanical circulatory support (pMCS) strategies in both high-risk PCI and cardiogenic shock.

Dr. Pal Soos interviews Prof. Dr. Christophe Vandenbriele, a cardiologist and intensivist from UZ Leuven (Belgium) and research fellow at Royal Brompton Hospital in London. Dr.

Vasileios Panoulas, MD, presents 3 patient case examples illustrating significant LV improvement with Impella-supported PCI.

Chuck Simonton, MD, provides an update on Impella® clinical trials including PROTECT III, RESTORE EF, and PROTECT IV RCT.

Discover the recordings of our scientific session at EACTS 2022 about "Innovative Strategies for Superior Outcome in Cardiac Surgery Including pMCS Support in Therapy Pathway".

Junya Ako, MD, discusses the J-PVAD registry and study data presented at TCT 2022 with Prof. Hermann Reichenspurner.

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock at TCT 2022. 

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day 1 of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.

Kate Kearney, MD, presents a case and discusses contemporary techniques for optimal outcomes in high-risk PCI at TCT 2022. 

This recap of highlights from day 2 of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller, and Taishi Hirai.

Day 3 highlights from TCT 2022 include several late-breaking trials and interviews with Navin Kapur, MD, and Koichi Toda, MD, PhD.

Adam Salisbury, MD, presents preliminary results from the OPTIMUM Study at TCT 2022.

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.